The KEGG pathway analysis showed that these targets were mainly associated with cancer, melanoma, platinum drug resistance, glioma, chronic myeloid leukemia, endocrine resistance, sphingolipid signaling pathway, neurotrophin signaling pathway, thyroid hormone signaling pathway, apoptosis, cellular senescence, hepatitis C, and hepatitis B (Figure 3). Here, TG is linked to chronic myelogenous leukemia, BCR-ABL1 positive.